Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:1098-1101
Published online before print March 24, 2005, doi: 10.1161/01.STR.0000162388.67745.8d
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/5/1098    most recent
01.STR.0000162388.67745.8dv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schellinger, P. D.
Right arrow Articles by Fiebach, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schellinger, P. D.
Right arrow Articles by Fiebach, J. B.
Related Collections
Right arrow Fibrinolysis
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow Thrombolysis
Right arrowRelated Articles

(Stroke. 2005;36:1098.)
© 2005 American Heart Association, Inc.


Controversies in Stroke

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours

Pro

Peter D. Schellinger, MD Jochen B. Fiebach, MD

From the Departments of Neurology (P.D.S.), and Neuroradiology (J.B.F.), University of Heidelberg, Germany.

Correspondence to Peter D. Schellinger, MD, Neurologische Universitatsklinik, Im Neuenheimer Feld 400, D-69120 Heidelberg, Germany. E-mail Peter-Schellinger@med.uni-heidelberg.de

Section Editors: Geoffrey A. Donnan MD, FRACP Stephen M. Davis MD, FRACP


Key Words: diffusion magnetic resonance imaging • magnetic resonance imaging


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

"It’s now or never. I was caught in a dead end street. A look (into your eyes) can heal me. And after this moment, you gave me something (back). What I really need."

Primal Fear, "Nuclear Fire," 2001

Of course, the "dead end street" refers to computed tomography (CT), "the healing look" to reading a stroke MRI, and being "given something that one really needs" to thrombolytic therapy.

What do we need to establish that a new methodology is ready to be put to use instead of an older one? We need to show that it is at least as good, if not better, than the old modality with regard to safety, feasibility, cost efficiency, and diagnostic and prognostic power. Over the last years, a growing number of reports on the use of multiparametric MRI protocols including diffusion-weighted imaging (DWI) and perfusion-weighted imaging (PWI) for guiding treatment in acute stroke patients have been published.1

MRI is safe in acute stroke patients; side effects such as allergic reactions to contrast agent and x-ray load virtually do not exist. Feasibility of stroke MRI is estimated between 75% and 95%,2–4 granted, somewhat lower than that of CT. The feasibility of stroke MRI depends in part on how patient instability, and therefore safety concerns, is defined in different centers. When compared with noncontrast CT alone, the cost of stroke MRI is higher; as soon as CT angiography and perfusion CT are added to the CT protocol, the difference in cost is marginal. Again, . . . [Full Text of this Article]


Related Articles:

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours: Con
Justin A. Zivin
Stroke 2005 36: 1099-1100. [Extract] [Full Text] [PDF]

Using Mismatch on MRI to Select Thrombolytic Responders: An Attractive Hypothesis Awaiting Confirmation
Stephen M. Davis and Geoffrey A. Donnan
Stroke 2005 36: 1100-1101. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
StrokeHome page
P. H. Mitchell, R. C. Veith, K. J. Becker, A. Buzaitis, K. C. Cain, M. Fruin, D. Tirschwell, and L. Teri
Brief Psychosocial-Behavioral Intervention With Antidepressant Reduces Poststroke Depression Significantly More Than Usual Care With Antidepressant: Living Well With Stroke: Randomized, Controlled Trial
Stroke, September 1, 2009; 40(9): 3073 - 3078.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. H. Pan, X. Y. Song, S. Y. Lee, and T. Kwok
Longitudinal Analysis of Quality of Life for Stroke Survivors Using Latent Curve Models
Stroke, October 1, 2008; 39(10): 2795 - 2802.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. Luby and S. Warach
Reliability of MR Perfusion-Weighted and Diffusion-Weighted Imaging Mismatch Measurement Methods
AJNR Am. J. Neuroradiol., October 1, 2007; 28(9): 1674 - 1678.
[Abstract] [Full Text] [PDF]


Home page
Clin RehabilHome page
A. M. Knottnerus, T. Turner-Stokes, F.B. van de Weg, L. Heijnen, G.J. Lankhorst, and L. Turner-Stokes
Diagnosis and treatment of depression following acquired brain injury: a comparison of practice in the UK and the Netherlands
Clinical Rehabilitation, September 1, 2007; 21(9): 805 - 811.
[Abstract] [PDF]


Home page
StrokeHome page
C. L. Watkins, M. F. Auton, C. F. Deans, H. A. Dickinson, C. I.A. Jack, C. E. Lightbody, C. J. Sutton, M. D. van den Broek, and M. J. Leathley
Motivational Interviewing Early After Acute Stroke: A Randomized, Controlled Trial
Stroke, March 1, 2007; 38(3): 1004 - 1009.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
Y. Chen, J. J Guo, S. Zhan, and N. C Patel
Treatment Effects of Antidepressants in Patients with Post-Stroke Depression: A Meta-Analysis
Ann. Pharmacother., December 1, 2006; 40(12): 2115 - 2122.
[Abstract] [Full Text] [PDF]